Top recalls for the week of Jan. 29 include Kias, Robitussin

Kia, Robitussin, Zenzedi, Tesla, eye drop recalls overview:

• Who: Kia, Robitussin, Zenzedi, Tesla and Kilitch Healthcare recalled products last week. 
• Why: The top recalls involve product safety and possible risk of harm. 
• Where: The recalls are effective in the United States.

Several popular companies, retailers and manufacturers announced recalls last week for products that may pose a risk of injury to consumers. Here are Top Class Actions’ top recalls for the week of Jan. 29.

Kia issues Sportage, Carnival recall over defective roof molding

Kia America initiated a recall affecting more than 100,000 model year 2022-2024 Carnival and Sportage models. 

Kia may have manufactured the vehicles with faulty roof molding, which can loosen and detach, causing a road hazard. 

Of the 101,049 vehicles included in the recall, Kia estimates around 1% may experience the defect, which is a result of improper installation or interference of the roof molding retaining clips with excessive roof panel sealer.

Kia says its dealers will conduct thorough inspections of the roof molding on the affected vehicles and replace or secure it as needed with no cost to the vehicle owners. 

Haleon recalls Robitussin CF Max over microbial contamination

Haleon announced the recall of eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult due to microbial contamination concerns. 

The recall includes specific lots of 4-ounce and 8-ounce Robitussin Honey CF Max Day Adult with expiration dates ranging from May 31, 2025, to Oct. 31, 2025. It also includes lots T08740 and T08742 of 8-ounce Robitussin Honey CF Max Nighttime Adult with an expiration date of June 30, 2026.

The microbial contamination can cause severe or life-threatening events, particularly for immunocompromised individuals who may experience conditions like fungemia or disseminated fungal infection, according to the recall notice.

Haleon has not received any reports of illness related to the recalled products, the recall notice says. The company is taking proactive measures by directly contacting customers and distributors affected by the recall. 

Customers seeking more information can contact Haleon’s consumer relations team at 800-245-1040 during regular business hours or via email at [email protected]. 

Zenzedi tablets recalled over due to mislabeled packaging

Azurity Pharmaceuticals announced a recall of a specific lot of Zenzedi CII 30-milligram narcolepsy tablets due to an inadvertent packaging error. 

The company initiated the recall after a Nebraska pharmacist discovered carbinoxamine maleate antihistamine tablets inside a Zenzedi bottle, raising concerns about potential risks associated with the mix-up. The inadvertent inclusion of the antihistamine tablets poses a threat of undertreating the narcolepsy symptoms for which Zenzedi is prescribed, the recall notice states. This can potentially lead to functional impairment and an elevated risk of accidents or injury. 

Azurity distributed the affected lot, with an expiration date of June 2025, to wholesalers from Aug. 23 to Nov. 29, 2023.

Zenzedi tablets, identifiable as light-yellow hexagonal tablets with markings “30” and “MIA,” are normally packaged in white bottles with black writing and a highlighted yellow “30 mg.” In contrast, the carbinoxamine maleate tablets are white, round and imprinted with “GL” on one side and “211” on the other. 

Azurity issued recall notices to wholesale distributors Jan. 4, urging consumers to stop using the affected pills and return them to the place of purchase. The company reports no serious adverse effects related to the narcolepsy tablet recall.

2023 Tesla Model S, X, Y recalled over rearview camera malfunction 

Tesla initiated a recall affecting nearly 200,000 of its model year 2023 Tesla Model S, X and Y vehicles due to concerns related to the rearview camera. The recall includes 199,575 vehicles equipped with a full self-driving computer 4.0, running specific software release versions from 2023.44.30 through 2023.44.30.6 or 2023.44.100. 

The identified issue involves a potential malfunction of the rearview camera, resulting in failure to display an image while backing up, according to the recall notice. This malfunction could elevate the risk of a collision.

Tesla has been proactive in addressing the concern, deploying an over-the-air software update at no cost to affected vehicle owners starting on or shortly after Dec. 28, 2023. The company says it notified all Tesla stores and service centers about the recall on or shortly after Jan. 24, 2024, and plans to send owner notification letters by March 22. 

Kilitch Healthcare India Ltd. expands eye drop recall 

Kilitch Healthcare India Limited updated a recall of eye drops sold under various brand names, including Rite Aid, CVS, Target, Walmart, Rugby, Velocity and Leader. 

The U.S. Food and Drug Administration’s (FDA) discovered insanitary conditions that could pose a risk of eye infections or potential harm to consumers, according to the recall notice. 

The recall now includes correct National Drug Code (NDC) numbers for two varieties of eye drops sold at Rite Aid. The 15-milliliter lubricant gel drops have NDC 11822-4540-5, while the 15-milliliter lubricant eye drops twin pack carries an NDC of 11822-4811-5.

Distributer Velocity Pharma LLC is notifying wholesalers and retailers of the recall and coordinating the return of impacted products, the recall states.

Have you purchased any of the products listed in our top recalls recently? Let us know in the comments. And be sure to check out other top recalls.

Read About More Class Action Lawsuits & Class Action Settlements:

• Consumers receive settlement payouts from Smashburger, Build-A-Bear, Dole, others
• Judge grants discovery extension in DoorDash fees class action 
• Judge approves $2M Bosch microwave oven settlement 
• Recent data breach incidents at Dropbox, 23andMe, other companies affect individuals in U.S. and worldwide